The Latest Breaking News from Oak Street Health

Upgrades

Over the past 3 months, 7 analysts have published their opinion on Oak Street Health (NYSE:OSH) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga Pro data, Oak Street Health (NYSE:OSH) reported Q4 sales of $394.10 million. Earnings fell to a loss of $140.30 million, resulting in a 27.66% decrease from last quarter.

Over the past 3 months, 4 analysts have published their opinion on Oak Street Health (NYSE:OSH) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.